Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hair loss doesn't affect COVID-19 severity.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Lower LDL-c levels predict higher COVID-19 mortality.

Social media data can help track and predict COVID-19 symptoms and trends.

Tocilizumab might be an effective treatment for COVID-19.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.